LAS ALGAS Y OTROS ORGANISMOS MARINOS COMO FUENTE DE MOLÉCULAS BIOACTIVAS
DOI:
https://doi.org/10.18633/bt.v15i1.132Resumen
En años recientes, el incremento en la resistencia a los fármacos antiproliferativos utilizados en el tratamiento del cáncer (Ling et al., 2010), así como en la resistencia bacteriana (Chang et al., 2003; Whichard et al., 2007) se han convertido en problemas de mucho interés para la salud pública. En la actualidad, no existe una terapia 100% efectiva contra el cáncer diseminado y aunque las terapias pueden ser altamente específicas, se ha observado que la resistencia es intrínseca al cáncer y a medida que las terapias son más efectivas, la resistencia adquirida también lo es (Gottesman, 2002). Por otro lado, Las infecciones causadas por bacterias resistentes no responden al tratamiento ordinario y como consecuencia se eleva el riesgo de mortalidad. Solo por citar un ejemplo, cada año se registran incidencias globales de 440000 casos de tuberculosis multirresistente con índices de mortalidad que superan las 150000 defunciones. La tuberculosis ultrarresistente se ha notificado en 64 países (OMS, 2012). El rápido aumento en la resistencia a los fármacos antiproliferativos y antibacterianos induce a tomar varias medidas de control, entre las cuales se puede mencionar la necesidad de buscar nuevas fuentes de moléculas bioactivas.Descargas
Citas
Abou Elalla, F. y Shalaby, E.A. 2009. Antioxidant Activity of Extract and Semi - Purified Fractions of Marine Red Macroalga, Gracilaria verrucosa. Australian Journal of Basic and Applied Sciences. 3(4):3179–3185.
Aneiros, A. y Garateix, A. 2004. Bioactive peptides from marine sources: pharmacological properties and isolation procedures. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 803(1):41–53.
Boonchum, W., Peerapornpisal, Y., Kanjanapothi, D., Pekkoh, J., Pumas, C., Jamjai, U., Amornlerdpison, D., Noiraksar, T. y Vacharapiyasophon, P. 2011. Antioxidant Activity of some Seaweed from the Gulf of Thailand. International Journal of Agriculture and Biology. 13:95–99.
Broggini, M., Marchini, S., Galliera, E., Borsotti, P., Taraboletti, G., Erba, E., Sironi, M., Jimeno, J., Faircloth, G., Giavazzi, R. y D`lncalci, M. 2003. Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4. Leukemia. 17:52–59.
Campbell, M. N. 2008. Biodiesel: Algae as a Renewable Source for Liquid Fuel. Guelph Engineering Journal, 1(1), 2–7.
Chang, S., Dawn, M., Sieverth, M., Hageman, J., Boulton, M., Tenover, F., Downes, F., Shah, S., Rudrik, J., Pupp, G., Brown, W., Cardo, D. y Fridkin, S. 2003. Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene. The new England Journal of Medicine. 348:1342–1347.
Chen, Y.H., Tu, C.J. y Wu, H.T. 2004. Growth-inhibitory effects of the red alga Gelidium amansii on cultured cells. Biological & pharmaceutical bulletin, 27(2):180–184.
Christian, B., Lichti, B., Pulz, O., Grewe, C., and Luckas, B. 2009. Fast and unambiguous determination of EPA and DHA content in oil of selected strains of algae and cyanobacteria. Acta Agronomica Hungarica, 57(2), 249–253.
Cifuentes-Barreto, M.C. 2010. Proceso biodirigido para la obtención de fracciones con actividad antitumoral a partir de Petiveria alliacea. Tesis Doctoral. Pontificia Universidad Javeriana.
Cooper, G. y Hausman, R. 2009. The cell. 5th ed. American Society for Microbiology. Edit. ASM Press and Sinauer Associates, Inc. Washington, D.C.
Echavarria, B., Franco, A. y Martinez, A. 2009. Evaluación de la actividad antioxidante y determinación del contenido de compuestos fenólicos en extractos de macroalgas del caribe colombiano. Vitae, Revista de la Facultad de Química Farmacéutica. 16(1):126–131.
El-Baky, H.H.A., Baz, F.K.E. y El-baroty, G.S. 2009. Production of phenolic compounds from Spirulina maxima microalgae and its protective effects. African Journal of Biotechnology. 8(24):7059–7067.
Gala, F., D´Auria, M.V., De Marino, S., Sepe, V., Zollo, F., Smith, C.D., Cooper, J.E. y Zampella, A. 2008. Jaspamides H–L, new actin-targeting depsipeptides from the sponge Jaspis splendans. Tetrahedron. 64:7127–7130.
García, D.E. 2004. Los metabolitos secundarios de las especies vegetales. Pastos y Forrajes. 27(1):1–12.
Gonzaga de Freitas Araújo, M., Hilario, F., Vilegas, W., Campaner dos Santos, L., Brunetti, I.L., Sotomayor, C.E. y Bauab, T.M. 2012. Correlation among Antioxidant, Antimicrobial, Hemolytic, and Antiproliferative Properties of Leiothrix spiralis Leaves Extract. International Journal of Molecular Sciences. 13(7):9260–9277.
Gottesman, M.M. 2002. Mechanisms of cancer drug resistance. Annual Reviews of Medicine. 53:615–627.
Ismail, M.F., Ali, D.A., Fernando, A., Abdraboh, M., Gaur, R.L., Ibrahim, W., Raj, M.H.J. y Ouhtit, A. 2009. Chemoprevention of rat liver toxicity and carcinogenesis by Spirulina. International journal of biological sciences. 5(4):377–387.
Jae-Suk, C., Yu-Mi, H., Chi-Un, J. y Kwang, K.C. 2012. Inhibition of oral pathogens and collagenase activity by seaweed extracts. Journal of Environmental Biology. 33:115–121.
Jeong, S., Higuchi, R., Miyamoto, T. Ono, M., Kuwano, M. y Mawatari, S. 2002. Bryoanthrathiophene, a New Antiangiogenic Constituent from the Bryozoan Watersipora subtorquata (d’ Orbigny , 1852). Journal of natural products. 65:1344–1345.
Jha, R.K. y Zi-rong, X. 2004. Biomedical compounds from marine organisms. Marine Drugs, 2:123–146.
Johnson, A. B., y O’Malley, B. W. 2011. ERasing breast cancer resistance through the kinome. Nature medicine, 17(6): 660–661.
Jumeri y Kim, S.M. 2011. Antioxidant and anticancer activities of enzymatic hydrolysates of solitary tunicate (Styela clava). Food Science and Biotechnology. 20(4):1075–1085.
Jung, W.K., Ju, H.Y., Qian, Z.J., Jeong, Y.J., Park, S.G., Choi, I.W. y Kim, S.K. 2007. A novel anticoagulant protein with high affinity to blood coagulation factor Va from Tegillarea granosa. Journal of Biochemistry and Molecular Biology. 40(5):832–838.
Lassen, K.M. 2011. The Synthesis and Biological Evaluation of Tamandarin B Analogs. Ph.D. Dissertation. University of Pennsylvania, Philadephia.
Lee, R. E. 2008. Phycology. 4th ed. Edit. Cambridge University Press. New York, USA.
Lee, S.H., Qian, Z.J. y Kim, S.K. 2010. A novel angiotensin I converting enzyme inhibitory peptide from tuna frame protein hydrolysate and its antihypertensive effect in spontaneously hypertensive rats. Food Chemistry. 118(1):96–102.
Ling, X., Zhou, Y., Li, S.W., Yan, B. y Wen, L. 2010. Modulation of Mitochondrial Permeability Transition Pore Affects Multi- drug Resistance in Human Hepatocellular Carcinoma Cells. International Journal of Biological Sciences. 6(7):773–783.
Madden, T., Tran, H.T., Beck, R.H., Newman, R.A., Pusztai, L., Wright, J.J. y Abbruzzese, J.L. 2000. Novel Marine-derived Anticancer Agents: A Phase I Clinical , Pharmacological, and Pharmacodynamic Study of Dolastatin 10 (NSC 376128) in Patients with Advanced Solid Tumors. Clinical Cancer Research. 6:1293–1301.
Madigan, M., Martinko, J. y Parker, J. 2006. Brock: Biología de los microorganismos. 10th ed. Edit.Pearson Prentice Hall. España.
Magallanes, C., Córdova, C. y Orozco, R. 2003. Actividad antibacteriana de extractos etanólicos de macroalgas marinas de la costa central del Perú. Revista Peruana de Biología. 10(2):125–132.
Mhadhebi, L., Laroche-Clary, A., Robert, J., y Bouraoui, A. 2011. Anti-inflammatory, anti-proliferative and anti-oxidant activities of organic extracts from the Mediterranean seaweed, Cystoseira crinita. African Journal of Biotechnology. 10(73):16682–16690.
Moo-Puc, R., Robledo, D. y Freile-Pelegrin, Y. 2009. In vitro cytotoxic and antiproliferative activities of marine macroalgae from Yucatán, Mexico. Ciencias Marinas. 35(4):345–358.
Moraes De Souza, M., Prietto, L., Ribeiro, A.C., Denardi De Souza, T. y Badiale-Furlong, E. 2011. Assessment of the antifungal activity of Spirulina platensis phenolic extract against Aspergillus flavus. Ciencias agrotecnológicas. Lavras. 35(6):1050–1058.
Nakanishi, R. 2012. Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression. Chinese Journal of Cancer, 31(2): 73–99.
Ngo, D.H., Vo, T.S., Ngo, D.N., Wijesekara, I. y Kim, S.K. 2012. Biological activities and potential health benefits of bioactive peptides derived from marine organisms. International Journal of Biological Macromolecules. 51(4):378–383.
OMS, 2012. Resistencia a los antimicrobianos (RAM). Organización mundial de la Salud. Centro de prensa. Nota descriptiva 194:1–5. Available at: http://www.who.int/mediacentre/factsheets/fs194/es/index.html.
Pardhasaradhi, B.V.V., Ali, A.M., Kumari, A.L., Reddanna, P. y Khar, A. 2003. Phycocyanin-mediated apoptosis in AK-5 tumor cells involves down-regulation of Bcl-2 and generation of ROS. Molecular Cancer Therapeutics, (2):1165–1170.
Payyavula, R.S., Navarre, D.A., Kuhl, J.C., Pantoja, A., y Pillai, S.S. 2012. Differential effects of environment on potato phenylpropanoid and carotenoid expression. BMC Plant Biology. 12(1):39-56.
Picot, L., Bordenave, S., Didelot, S., Fruitier-Arnanudin, I., Sannier, F., Thorkelsson, G., Berge, J.P., Guérard, F., Chabeaud, A. y Piot, J.M. 2006. Antiproliferative activity of fish protein hydrolysates on human breast cancer cell lines. Process Biochemistry, 41(5):1217–1222.
Piñero Estrada, J.E., Bermejo Bescós, P. y Villar del Fresno, M. 2001. Antioxidant activity of different fractions of Spirulina platensis protean extract. Farmaco (Società chimica italiana: 1989). 56(5-7):497–500.
Ríos, N., Medina, G., Jiménez, J., Yánez, C., García, M.Y., Di Bernardo, M.L. y Gualtieri, M. 2009. Antibacterial and antifungal activity from extracts of Venezuelan marine algae. Revista Peruana de Biología. 16(1):97–100.
Santafé, G., Paz, V., Rodríguez, J. y Jiménez, C. 2002. Novel cytotoxic oxygenated C29 sterols from the Colombian marine sponge Polymastia tenax. Journal of Natural Products. 65:1161–1164.
Spijkerman, E., Wacker, A., Weithoff, G., y Leya, T. 2012. Elemental and fatty acid composition of snow algae in Arctic habitats. Frontiers in microbiology, 3(October), 1 - 15.
Stevenson, C.S., Capper, E.A., Roshak, A.K., Marquez, B., Eichman, C., Jackson, J.R., Mattern, M., Gerwick, W.H., Jacobs, R.S. y Marshall, L. 2002. The Identification and Characterization of the Marine Natural Product Scytonemin as a Novel Antiproliferative Pharmacophore. The Journal of Pharmacology and Experimental Therapeutics. 303:858–866.
Suarez-Jimenez, G.M., Burgos-Hernandez, A. y Ezquerra-Brauer, J.M. 2012. Bioactive peptides and depsipeptides with anticancer potential: sources from marine animals. Marine Drugs. 10(5):963–986.
Vallinayagam, K., Arumugam, R., Ragupathi Raja Kannan, R., Thirumaran, G., Anantharaman, P. 2009. Antibacterial Activity of Some Selected Seaweeds from Pudumadam Coastal Regions. Global Journal of Pharmacology. 3(1):50–52.
Vijayabaskar, P. y Shiyamala, V. 2011. Antibacterial Activities of Brown Marine Algae (Sargassum wightii and Turbinaria ornata) from the Gulf of Mannar Biosphere Reserve. Advances in Biological Research. 5(2):99–102.
Villareal-Gómez, L., Soria-Mercado, I.E., Guerra-Rivas, G. y Ayala-Sánchez, N.E. 2010. Antibacterial and anticancer activity of seaweeds and bacteria associated with their surface. Revista de Biología Marina y Oceanografía, 45(2):267–275.
Wang, Y.K., He, H.L., Wang, G.F. Wu, H., Zhou, B.C., Chen, X.L. y Zhang, Y.Z. 2010. Oyster (Crassostrea gigas) hydrolysates produced on a plant scale have antitumor activity and immunostimulating effects in BALB/c mice. Marine Drugs. 8(2):255–268.
Wergedahl, H., Liaset, B., Gudbrandsen, O.A., Lied, E., Espe, M., Muna, Z., Mork, S. y Berge, R.K. 2004. Fish Protein Hydrolysate Reduces Plasma Total Cholesterol , Increases the Proportion of HDL Cholesterol, and Lowers Acyl-CoA: Cholesterol Acyltransferase Activity in Liver of Zucker Rats. The Journal of Nutrition. 134:1320–1327.
Whichard, J.M., Gay, K., Stevenson, J.E., Joyce, K.J., Cooper, K.L., Omondi, M., Medalla, F., Jacoby, G.A. y Barrett, T.J. 2007. Human Salmonella and concurrent decreased susceptibility to quinolones and extended-spectrum cephalosporins. Emerging infectious diseases. 13(11):1681–1688.
Wilson-Sanchez, G., Moreno-Félix, C., Velazquez, C., Plascencia-Jatomea, M., Acosta, A., Machi-Lara, L., Aldana-Madrid, M.L., Ezquerra-Brauer, J.M., Robles-Zepeda, R. y Burgos-Hernandez, A. 2010. Antimutagenicity and antiproliferative studies of lipidic extracts from white shrimp (Litopenaeus vannamei). Marine Drugs. 8(11):2795–2809.
Zandi, K., Tajbakhsh, S., Nabipour, I., Rastian, Z., Yousefi, F., Sharafian, S. y Sartavi, K. 2010. In vitro antitumor activity of Gracilaria corticata (a red alga) against Jurkat and molt-4 human cancer cell lines. African Journal of Biotechnology. 9(40):6787–6790.
Zandi, K., Farsangi, M.H., Nabipour, I., Soleimani, M., Khajeh, K., Sajedi, R.H. y Jafari, S.M. 2007. Isolation of a 60 kDa protein with in vitro anticancer activity against human cancer cell lines from the purple fluid of the Persian Gulf sea hare, Aplysia dactylomela. African Journal of Biotechnology. 6:1280–1283.
Zheng, L.H., Wang, Y.J., Sheng, J., Wang, F., Zheng, Y., Lin, X.K. y Sun, M. 2011. Antitumor peptides from marine organisms. Marine drugs, 9(10), pp.1840–59.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
La revista Biotecnia se encuentra bajo la licencia Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
_(2).jpg)
